Iambic Therapeutics vs Relay Therapeutics
Iambic Therapeutics vs Relay Therapeutics, compared side by side on 19 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Iambic Therapeutics is on 61/100 and Relay Therapeutics on 58/100.
Where each one leads
Iambic Therapeutics
Leads on none of the measures we hold for both companies.
Relay Therapeutics
- agent readiness: 39/100 against 31/100
- funding raised: $825M against $50.0M
At a glance
| Measure | Iambic Therapeutics | Relay Therapeutics |
|---|---|---|
| What it is | AI-driven drug discovery company developing novel medicines for unmet patient needs. | Clinical-stage precision medicine company using protein motion insights for drug discovery. |
| Category | Biotech, HealthTech, Drug Discovery, AI-Driven Drug Discovery | Biotech, Drug Discovery, Precision Medicine, Oncology |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Platform |
| Founded | 2019 | 2015 |
| Headquarters | San Diego, United States | Cambridge, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Iambic Therapeutics | Relay Therapeutics |
|---|---|---|
| Employees | 151 | Not published |
| Total funding | $50.0M | $825M |
| Latest round | Series B Extension | Public Offering |
| LinkedIn followers | 17,283 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Iambic Therapeutics | Relay Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 61/100 | 58/100 |
| Traction | 60/100 | 40/100 |
| Team | 70/100 | 70/100 |
| Community | 15/100 | 8/100 |
| Search visibility | 36/100 | 14/100 |
| Quality | 68/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (31/100) | F (39/100) |
| Domain ratingLink authority, 0-100 | 48/100 | 45/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Iambic Therapeutics | Relay Therapeutics |
|---|---|---|
| CDN | Cloudflare | Cloudflare |
| CMS | Webflow | WordPress |
| Frameworks | Not detected | Jquery |
| Analytics | Not detected | Linkedin Insight |
Iambic Therapeutics vs Relay Therapeutics: common questions
Which is better, Iambic Therapeutics or Relay Therapeutics?
On our 0-100 score Iambic Therapeutics rates higher (61/100 against 58/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 19 data points above: read the rows that match what you are buying for.
How do Iambic Therapeutics and Relay Therapeutics compare on the numbers?
Relay Therapeutics leads on agent readiness (39/100 against 31/100), funding raised ($825M against $50.0M).
Read the full Iambic Therapeutics review and pricing or the Relay Therapeutics review and pricing. You can also browse other Iambic Therapeutics alternatives we track.